V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Market Cap: 10.8B CHF
Have any thoughts about
Vifor Pharma AG?
Write Note

Vifor Pharma AG
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Cost of Revenue Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Cost of Revenue
-CHf671.8m
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
13%
Novartis AG
SIX:NOVN
Cost of Revenue
-$12.3B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
3%
Roche Holding AG
SIX:ROG
Cost of Revenue
-CHf15.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
-2%
S
Sandoz Group AG
SIX:SDZ
Cost of Revenue
-$5.3B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Cost of Revenue?
Cost of Revenue
-671.8m CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Cost of Revenue amounts to -671.8m CHF.

What is Vifor Pharma AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
13%

Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for Vifor Pharma AG have been -1% over the past three years , -9% over the past five years , and 13% over the past ten years .

Back to Top